Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C.

The combination of LSM and circulating hyaluronic acid measurements significantly improved prognostic ability, relative to LSM alone. Combined static and dynamic markers of liver fibrosis could provide superior risk prediction.